188 related articles for article (PubMed ID: 16102623)
41. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
Gilard M; Arnaud B; Cornily JC; Le Gal G; Lacut K; Le Calvez G; Mansourati J; Mottier D; Abgrall JF; Boschat J
J Am Coll Cardiol; 2008 Jan; 51(3):256-60. PubMed ID: 18206732
[TBL] [Abstract][Full Text] [Related]
42. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial.
Yong G; Rankin J; Ferguson L; Thom J; French J; Brieger D; Chew DP; Dick R; Eccleston D; Hockings B; Walters D; Whelan A; Eikelboom JW
Am Heart J; 2009 Jan; 157(1):60.e1-9. PubMed ID: 19081397
[TBL] [Abstract][Full Text] [Related]
43. Week-long high-maintenance dose clopidogrel regimen achieves better platelet aggregation inhibition than a standard loading dose before percutaneous coronary intervention: results of a double-blind, randomized clinical trial.
Nguyen TA; Lordkipanidzé M; Diodati JG; Palisaitis DA; Schampaert E; Turgeon J; Pharand C
J Interv Cardiol; 2009 Aug; 22(4):368-77. PubMed ID: 19689661
[TBL] [Abstract][Full Text] [Related]
44. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation.
Juergens CP; Wong AM; Leung DY; Lowe HC; Lo S; Fernandes C; Newland EF; Hopkins AP
Am Heart J; 2004 Apr; 147(4):E15. PubMed ID: 15077098
[TBL] [Abstract][Full Text] [Related]
45. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
[TBL] [Abstract][Full Text] [Related]
46. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension.
Robbins IM; Kawut SM; Yung D; Reilly MP; Lloyd W; Cunningham G; Loscalzo J; Kimmel SE; Christman BW; Barst RJ
Eur Respir J; 2006 Mar; 27(3):578-84. PubMed ID: 16507859
[TBL] [Abstract][Full Text] [Related]
47. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
Kamath S; Blann AD; Chin BS; Lip GY
J Am Coll Cardiol; 2002 Aug; 40(3):484-90. PubMed ID: 12142115
[TBL] [Abstract][Full Text] [Related]
48. Clopidogrel use before renal artery angioplasty with/without stent placement resulted in tertiary procedure risk reduction.
Mousa AY; Broce M; Campbell J; Nanjundappa A; Stone PA; Abu-Halimah S; Srivastava M; Bates MC; Aburahma AF
J Vasc Surg; 2012 Aug; 56(2):416-23. PubMed ID: 22560231
[TBL] [Abstract][Full Text] [Related]
49. Pretreatment with antithrombotic agents during radiofrequency catheter ablation: a randomized comparison of aspirin versus ticlopidine.
Manolis AS; Maounis T; Vassilikos V; Melita-Manolis H; Psarros L; Terzoglou G; Cokkinos DV
J Cardiovasc Electrophysiol; 1998 Nov; 9(11):1144-51. PubMed ID: 9835257
[TBL] [Abstract][Full Text] [Related]
50. [Indirect comparison of changes of parameters of hemostasis during short-term use of ticlopidine and clopidogrel in patients with non-ST elevation acute coronary syndrome].
Slavina NN; Averkov OV; Gratsianskiĭ NA
Kardiologiia; 2005; 45(12):11-6. PubMed ID: 16353041
[TBL] [Abstract][Full Text] [Related]
51. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].
Jia XQ; Dong CM; Qin J; Zhang L
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):225-8. PubMed ID: 22464576
[TBL] [Abstract][Full Text] [Related]
52. Activated coagulation during open and endovascular abdominal aortic aneurysm repair.
Englberger L; Savolainen H; Jandus P; Widmer M; Do do D; Haeberli A; Baumgartner I; Carrel TP; Schmidli J
J Vasc Surg; 2006 Jun; 43(6):1124-9. PubMed ID: 16765226
[TBL] [Abstract][Full Text] [Related]
53. D-dimer testing in the diagnosis of transfemoral pseudoaneurysm after percutaneous transluminal procedures.
Hoke M; Koppensteiner R; Schillinger M; Haumer M; Minar E; Wiesbauer F; Huber CD; Mlekusch W
J Vasc Surg; 2010 Aug; 52(2):383-7. PubMed ID: 20488641
[TBL] [Abstract][Full Text] [Related]
54. Tissue factor and other hemostatic parameters in patients with advanced peripheral artery disease after endovascular revascularization - search for hemostatic factors which indicate restenosis.
Kotschy D; Kotschy M; Socha P; Masłowski L; Kwapisz J; Żuk N; Dubis J; Karczewski M; Witkiewicz W
Adv Clin Exp Med; 2015; 24(1):93-8. PubMed ID: 25923092
[TBL] [Abstract][Full Text] [Related]
55. Thrombin generation and platelet activation related to subintimal percutaneous transluminal angioplasty.
Jenssen EK; Brosstad F; Pedersen T; Bjørnsen S; Jørgensen JJ; Sandbæk G
Scand J Clin Lab Invest; 2012 Feb; 72(1):23-8. PubMed ID: 22149451
[TBL] [Abstract][Full Text] [Related]
56. The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication: a randomized controlled trial.
Hobbs SD; Marshall T; Fegan C; Adam DJ; Bradbury AW
J Vasc Surg; 2007 Jan; 45(1):65-70; discussion 70. PubMed ID: 17210383
[TBL] [Abstract][Full Text] [Related]
57. [Non ST elevation acute coronary syndrome. Parameters of fibrinolysis during short term use of ticlopidine or clopidogrel].
Slavina NN; Averkov OV; Dobrovol'skiĭ AB; Gratsianskiĭ NA
Kardiologiia; 2003; 43(7):4-11. PubMed ID: 12891293
[TBL] [Abstract][Full Text] [Related]
58. Risk reduction with clopidogrel in the management of peripheral arterial disease.
Nayak KR; Cavendish JJ
Vasc Health Risk Manag; 2007; 3(3):289-97. PubMed ID: 17703636
[TBL] [Abstract][Full Text] [Related]
59. Clinical implication of plasma level of soluble fibrin monomer-fibrinogen complex in patients with abdominal aortic aneurysm.
Hosaka A; Miyata T; Aramoto H; Shigematsu H; Nakazawa T; Okamoto H; Shigematsu K; Nagawa H
J Vasc Surg; 2005 Aug; 42(2):200-5. PubMed ID: 16102614
[TBL] [Abstract][Full Text] [Related]
60. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
